In a second series of experiments, we directly quantified the aromatase activity of glioma cells, finding that this was reduced by melatonin at 1 mM concentration, the same concentration that causes the greatest antiproliferative effects in these cells (Martín et al, 2006). This evidence concerns the gene CYP19A1 and central nervous system cancer.